Concepedia
Author
H Isomäki
Also Known As
H ISOMÄKI, H Isomaki, H Isomäki, H. A. Isomaki, H. A. Isomäki, H. ISOMÄKI, H. Isomaki, H. Isomäki, H.A. Isomäki, HA Isomäki
150
Publications
4.8K
Citations
35
H-Index
98
Concepts
All Affiliations
1
25
48
3K
2
8
465
3
5
428
4
397
20
×
All Concepts
74
4.5K
33
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
H Isomäki, Timo Hakulinen, U. Joutsenlahti
Journal of Chronic Diseases
Hematological MalignancyRheumatologyLymphoid NeoplasiaEpidemiologyRheumatoid Disorder +9
1978
432
Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis
Kaisa Granfors, Sirpa Jalkanen, O. Mäki‐Ikola, +7
The Lancet
InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseTyphoid Fever +9
1990
310
Ten year mortality and causes of death in patients with rheumatoid arthritis.
O. Mutru, Markku Laakso, H Isomäki, +1
BMJ
Rheumatoid DisorderRheumatologyTime 352EpidemiologyAutoimmune Disease +13
1985
265
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment [published erratum appears in Br J Rheumatol 1998 Oct;37(10):1142]
C J Hawkey, André Kahan, Klaus Steinbrück, +8
Lara D. Veeken
Gastrointestinal PharmacologyGastroenterologyPharmacotherapyGi Adverse EventsInflammatory Arthritis +16
1998
259
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX- inhibiting Therapies (SELECT) trial in osteoarthritis
J. Dequeker, Christopher J. Hawkey, André Kahan, +8
Efficacy Large-scale EvaluationGastrointestinal PharmacologyPharmacotherapySelective CyclooxygenaseOrthopaedic Surgery +16
225
Elevated cancer incidence in patients with dermatomyositis: a population based study.
Antti Airio, Eero Pukkala, H Isomäki
PubMed
1995
190
Cardiovascular mortality in women with rheumatoid arthritis.
R Myllykangas-Luosujärvi, Aho K, Hannu Kautiainen, +1
155
Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis.
115
Prognosis of Inflammatory Joint Diseases: A Three-year Follow-up Study
M. Nissilä, H Isomäki, K. Kaarela, +3
Scandinavian Journal of Rheumatology
1983
105
Death Rate and Causes of Death in RA Patients During a Period of Five Years
K Koota, H Isomäki, O. Mutru
PathologyMortality RatesPsoriatic ArthritisDeath RateRheumatoid Disorder +14
1977
100
Page 1